Waldencast Acquisition Corp. (WALD) Adds $225M Debt Facility to OBAGI and Milk Deal
by Nicholas Alan Clayton on 2022-06-27 at 11:03am

Waldencast Acquisition Corp. (NASDAQ:WALD) announced this morning that it has added $225 million in debt to its combination with beauty brands OBAGI and Milk.

This new money comes in the form of a four-year secured first-lien made up of a $175 million term loan and a $50 million revolving loan facility with $7.5 million available to be drawn as letters of credit. JP Morgan Chase (NYSE:JPM), Santander (NYSE:SAN) and Wells Fargo (NYSE:WFC) served as joint bookrunners and lead arrangers for the facility with JPM serving as administrative agent and Credit Suisse (NYSE:CS) as documentation agent.

The combined company would now receive $1.02 billion in total proceeds as this debt joins $333 million in forward purchase agreements (FPAs), a $113 million PIPE and Waldencast’s $345 million trust before redemptions. The PIPE and FPAs already covered the $440 million collective minimum cash conditions for the two companies, but the debt further secures all of the uses that the targets had in mind.

At announcement, the parties envisaged paying out $520 million in cash consideration to selling shareholders of the two companies and this new facility is aimed at paying down and replacing all of the companies’ existing credit facilities as well. Even in a 100% redemptions scenario, the combined company is now expected to have about $94 million in new capital to work with after expenses and consideration to sellers.

Waldencast initially announced the $1.2 billion combination with OBAGI and Milk Makeup on November 15. OBAGI provides medical-grade skincare products and Milk Makeup provides clean 100% vegan cosmetics via retail stores and its native ecommerce site.

The parties have not yet set a date for a completion vote on the deal, but on June 13, Waldencast announced an agreement with Obagi and Cedarwalk pertaining to the value of and cost associated with inventory on hand. As of five business days before the special shareholder meeting, the cost of inventory will be deducted from the cash portion of the consideration payable under the Obagi merger agreement to Cedarwalk.

Obagi Hong Kong will pay Obagi and certain affiliates a royalty of 2.75% of gross sales on the specific inventory identified in the agreement that is sold during the 90 days following the completion of the transaction.

 

Recent Posts
by Nicholas Alan Clayton on 2025-02-13 at 8:19am

At the SPAC of Dawn  The sudden burst of SPAC activity this week slowed down after the closing bell yesterday as the market faces a period sandwiched between CPI and PPI readouts. Yesterday’s CPI news and Fed Chair Jerome Powell’s comments before Congress did not provide an instant relief in terms of clarity on a...

by Kristi Marvin on 2025-02-12 at 5:34pm

Maywood Acquisition Corp. (NASDAQ:MAYAU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “MAYAU”, Thursday, February 13, 2025. Maywood will have a broad search focus and will pursue an initial business combination in any industry or geographic location. The team is led...

by Nicholas Alan Clayton on 2025-02-12 at 5:20pm

Artius II Acquisition Inc. (NASDAQ:AACBU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “AACBU”, Thursday, February 13, 2025. Artius II intends to search for a target company with a technology-enabled business with opportunities that have multiple vectors to create value post-combination....

by Kristi Marvin on 2025-02-12 at 5:08pm

It’s been an active week for Cohen & Company having filed four new SPACs in less than a week. Crane Harbor Acquisition Corp. (NASDAQ:CHACU) is the latest Cohen IPO filing and shows the former Osprey team as sponsors. Name changes for teams have been a trend for the past year or so and feels a...

by Nicholas Alan Clayton on 2025-02-12 at 2:42pm

Harvard Ave Acquisition Corporation (NASDAQ:HAVAU) has filed for a $250 million SPAC in a deal that significantly nudges upwards the prominence of D. Boral in the 2025 SPAC market to-date. Early 2025 filing activity has brought out some of the most biggest underwriters in SPACs, but, with Harvard Ave, the title of largest proposed SPAC...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved